Novel cytokine zcytor17 ligand

Details for Australian Patent Application No. 2003225525 (hide)

Owner ZymoGenetics, Inc.

Inventors Hammond, Angela K; Kuijper, Joseph L; Gross, Jane A; Dasovich, Maria M; Dillon, Stacey R; Sprecher, Cindy A; Novak, Julia E; Grant, Francis J

Agent Spruson & Ferguson

Pub. Number AU-B-2003225525

PCT Number PCT/US03/01984

PCT Pub. Number WO2003/060090

Priority 60/435,315 19.12.02 US; 60/375,323 25.04.02 US; 60/350,325 18.01.02 US

Filing date 21 January 2003

Wipo publication date 30 July 2003

Acceptance publication date 24 July 2008

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 1/02 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 15/08 (2006.01) Drugs for genital or sexual disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/52 (2006.01) Peptides having more than 20 amino acids

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 19/00 (2006.01) Hybrid peptides

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/19 (2006.01) Mutation or genetic engineering - Interferons

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 60/435,315 19.12.02 US; 60/375,323 25.04.02 US; 60/350,325 18.01.02 US

4 September 2003 Application Open to Public Inspection

  Published as AU-B-2003225525

24 July 2008 Application Accepted

  Published as AU-B-2003225525

20 November 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003225526-FORMATION PROCEDURE FOR ALKALINE NICKEL-ZINC CELLS

2003225524-Integrated entry air cushion marine vessel and marine platform